3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Keratosis, Actinic
5
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
2
Papillomavirus Infections
2
Melanoma
2
Hemangioma, Capillary
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sexually Transmitted Diseases
1
Precancerous Conditions
1
Pigmentation Disorders
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hemangioma
1
HPV
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Condylomata Acuminata
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Carcinoma in Situ
1
Interventions
Radiotherapy
4
fludarabine phosphate
2
aldesleukin
2
Paclitaxel
2
Nivolumab
2
Bevacizumab
2
zimberelimab
1
rocakinogene sifuplasmid
1
liposomal doxorubicin
1
fludarabine
1
durvalumab
1
dostarlimab
1
belzutifan
1
alovudine
1
Watchful Waiting
1
Vaccines, Synthetic
1
VGX-3100
1
Therapeutic Touch
1
Specimen Handling
1
Ritonavir
1
Radiosurgery
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Papillomavirus Vaccines
1
Observation
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Ipilimumab
1
Indinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Vaginal Neoplasms
×
Imiquimod
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled